{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:37:41Z","timestamp":1768473461634,"version":"3.49.0"},"reference-count":18,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T00:00:00Z","timestamp":1179187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tranexamic acid is one of the widely used antifibrinolytic agents. In spite of its effective inhibitory activity against plasminogen, thromboembolic adverse events caused by tranexamic acid are rare. We encountered three recipients of allogeneic hematopoietic stem cell transplantation (HSCT) who developed hepatic veno\u2010occlusive disease (VOD) shortly after the administration of tranexamic acid. Hepatic VOD was resolved completely in all patients with the discontinuation of the drug, and with supportive measures with or without intravenous tissue plasminogen activator administration. These findings suggest that administration of tranexamic acid could be one of the possible risk factors for developing hepatic VOD in HSCT recipients. Am. J. Hematol., 2007. \u00a9 2007 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.20958","type":"journal-article","created":{"date-parts":[[2007,5,15]],"date-time":"2007-05-15T16:21:40Z","timestamp":1179246100000},"page":"838-839","source":"Crossref","is-referenced-by-count":8,"title":["Hepatic veno\u2010occlusive disease after tranexamic acid administration in patients undergoing allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1002","volume":"82","author":[{"given":"Takehiko","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Aisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,6]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-4-199302150-00003"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.9r200.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702376"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00688324"},{"key":"e_1_2_1_6_2","first-page":"135","article-title":"Risk factors for hepatic veno\u2010occlusive disease after high\u2010dose busulfan\u2010containing regimens followed by autologous bone marrow transplantation: A study in 136 children","volume":"10","author":"Meresse V","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1182\/blood.V79.10.2784.2784","article-title":"Marked increase in veno\u2010occlusive disease of the liver associated with methotrexate use for graft\u2010versus\u2010host disease prophylaxis in patients receiving busulfan\/cyclophosphamide","volume":"79","author":"Essel JH","year":"1992","journal-title":"Blood"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-10-3821"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390407"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957060-00017"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262150-00003"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-200007000-00006"},{"key":"e_1_2_1_13_2","first-page":"714","article-title":"No increased risk of venous thrombosis in women taking tranexamic acid","volume":"86","author":"Berntorp E","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_1_14_2","first-page":"516","article-title":"Prophylactic use of tranexamic acid and incidence of arterial thrombosis in liver transplantation","volume":"93","author":"Dalmau A","year":"2001","journal-title":"Anesth Analg"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1742-1241.1989.tb08809.x","article-title":"Massive pulmonary throboembolism after tranexamic acid fibrinolytic therapy","volume":"43","author":"Woo KS","year":"1989","journal-title":"Br J Clin Pract"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2002.01607.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909093722"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.6.2184"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2681"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.20958","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.20958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:59:19Z","timestamp":1699984759000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.20958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,6]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1002\/ajh.20958"],"URL":"https:\/\/doi.org\/10.1002\/ajh.20958","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,6]]}}}